Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug Repurposing for Rare Diseases
Helen I. Roessler, Nine Knoers, Mieke M. van Haelst, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 255-267
Open Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

AlphaFold, Artificial Intelligence (AI), and Allostery
Ruth Nussinov, Mingzhen Zhang, Yonglan Liu, et al.
The Journal of Physical Chemistry B (2022) Vol. 126, Iss. 34, pp. 6372-6383
Open Access | Times Cited: 109
Enhancing Equitable Access to Rare Disease Diagnosis and Treatment around the World: A Review of Evidence, Policies, and Challenges
Takeya Adachi, Ayman W. El‐Hattab, Ritu Jain, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 6, pp. 4732-4732
Open Access | Times Cited: 78
Drug discovery and development: introduction to the general public and patient groups
Natesh Singh, Philippe Vayer, Shivalika Tanwar, et al.
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 77
Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy
Freya R. Weth, Georgia B. Hoggarth, Anya F. Weth, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 5, pp. 703-715
Open Access | Times Cited: 70
RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates
Massimo Rugge, Robert M. Genta, Peter Malfertheiner, et al.
Gut (2024), pp. gutjnl-331164
Open Access | Times Cited: 41
Drug repurposing for rare: progress and opportunities for the rare disease community
Anneliene Hechtelt Jonker, Daniel O’Connor, Maria Cavaller-Bellaubi, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 22
TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro
Qing-Qing Duan, Han Wang, Wei‐Ming Su, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Wen‐Jing Xiao, Wenjie Jiang, Zheng Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
How can natural language processing help model informed drug development?: a review
Roopal Bhatnagar, Sakshi Sardar, Maedeh Beheshti, et al.
JAMIA Open (2022) Vol. 5, Iss. 2
Open Access | Times Cited: 44
New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116569-116569
Closed Access | Times Cited: 16
Antibiotics: From Mechanism of Action to Resistance and Beyond
Shyamalima Saikia, Pankaj Chetia
Indian Journal of Microbiology (2024) Vol. 64, Iss. 3, pp. 821-845
Closed Access | Times Cited: 11
Artificial intelligence for drug repurposing against infectious diseases
Anuradha Singh
Artificial Intelligence Chemistry (2024) Vol. 2, Iss. 2, pp. 100071-100071
Open Access | Times Cited: 9
Advantages, Challenges, and Impact of Drug Repurposing for Cancer Treatment
Rabia Zafar, Iqra Safdar, Aiman Munir, et al.
IntechOpen eBooks (2025)
Closed Access | Times Cited: 1
Targeting Glucosylceramide Synthase: Innovative Drug Repurposing Strategies for Lysosomal Diseases
Giorgia Canini, Elena Mazzinelli, Giuseppina Nocca, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2195-2195
Open Access | Times Cited: 1
Virtual screening for small-molecule pathway regulators by image-profile matching
Mohammad Hossein Rohban, Ashley M. Fuller, Ceryl Tan, et al.
Cell Systems (2022) Vol. 13, Iss. 9, pp. 724-736.e9
Open Access | Times Cited: 30
Introduction to small molecule drug discovery and preclinical development
Michelle Southey, Michael Brunavs
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 19
New drug approvals for 2022: Synthesis and clinical applications
Shuo Yuan, Dandan Shen, Rui Jia, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2352-2391
Closed Access | Times Cited: 18
Trends in orphan medicinal products approvals in the European Union between 2010–2022
L. Bouwman, Bruno Sepodes, Hubert G. M. Leufkens, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8
New perspective of small-molecule antiviral drugs development for RNA viruses
Shasha Li, Huixia Li, Ruiya Lian, et al.
Virology (2024) Vol. 594, pp. 110042-110042
Closed Access | Times Cited: 8
Databases of ligand-binding pockets and protein-ligand interactions
Kristy A. Carpenter, Russ B. Altman
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 1320-1338
Open Access | Times Cited: 8
Artificial intelligence in drug repurposing for rare diseases: a mini-review
Lucas Cortial, Vincent Montero, Sébastien Tourlet, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 7
Toward structure–multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective
Edgar López‐López, José L. Medina‐Franco
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104046-104046
Closed Access | Times Cited: 7
Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders
Valeria Maria Pinto, Filippo Mazzi, Lucia De Franceschi
Blood (2024) Vol. 144, Iss. 8, pp. 853-866
Open Access | Times Cited: 7
The promise and challenges of genomics‐informed periodontal disease diagnoses
Luigi Nibali, Kimon Divaris, Emily Ming‐Chieh Lu
Periodontology 2000 (2024) Vol. 95, Iss. 1, pp. 194-202
Open Access | Times Cited: 7
Techniques and Strategies in Drug Design and Discovery
George Mihai Nițulescu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1364-1364
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top